Amgen's most recent trend suggests a bearish bias. One trading opportunity on Amgen is a Bear Call Spread using a strike $165.00 short call and a strike $175.00 long call offers a potential 14.55% return on risk over the next 38 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $165.00 by expiration. The full premium credit of $1.27 would be kept by the premium seller. The risk of $8.73 would be incurred if the stock rose above the $175.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Amgen is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Amgen is bearish.
The RSI indicator is at 45.65 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Amgen
Amgen Maintains 2015 View, Expects Several Drug Launches – Analyst Blog
Wed, 14 Jan 2015 20:40:08 GMT
Biotech Stock Roundup: Shire to Acquire NPSP, Celgene & Pharmacyclics Give Strong Outlook – Analyst Blog
Wed, 14 Jan 2015 19:39:07 GMT
Express Scripts sees opportunity to lower cancer treatment cost
Tue, 13 Jan 2015 21:28:41 GMT
Reuters – Express Scripts, the largest U.S. pharmacy benefit manager, on Tuesday said cost savings on expensive cancer treatments could be achieved if the company were involved earlier in the decision-making process. …
The Poster Child For Risk and Reward
Tue, 13 Jan 2015 18:23:00 GMT
Amgen and MD Anderson Announce Agreement to Develop BiTE® Therapies for Myelodysplastic Syndrome
Mon, 12 Jan 2015 21:36:30 GMT
noodls – THOUSAND OAKS, Calif. and HOUSTON, Jan. 12, 2015 /PRNewswire/ — Amgen (NASDAQ: AMGN) and The University of Texas MD Anderson Cancer Center today announced a research collaborative agreement focusing on …
Related Posts
Also on Market Tamer…
Follow Us on Facebook